James Richardson is listed as a director on 3 SEC Form D filings by 2 issuers between Oct 2013 and Nov 2016: Monteris Medical US, Inc. (Minnetonka, MN — other health care — 2014–2016; $26.6M reported sold to 10 investors) and MONTERIS MEDICAL HOLDINGS, INC (Plymouth, MN — biotechnology — 2013; $3.67M reported sold to 7 investors).
What this means 2 separate companies raised money with this person listed as director, over about 3 years. Across those companies the filings report $30.3M sold in total.
Listed alongside Daniel Cole (3 shared filings), Gregory Barrett (3 shared filings), Gary Bantle (2 shared filings), John Schellhorn (2 shared filings), Kevin McGarry (2 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around James. Each name links to their own page.
1 of the issuers belongs to the sponsor group Monteris (14 issuers, $162.9M reported sold, 2014–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Monteris has 14 companies on file and $162.9M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for James Richardson and found 8 differences: No amendment in the last 12 months on an offering that may still be open; Industry group changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.